Financials

Discussions Technicals Seasonals

MDIN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

MedGen, Inc. engages in the manufacture, sale, and licensing of healthcare products. Its product portfolio includes SNORenz, SNORenz Night-Time, Sombium, Focamine, Wide Awake, Stem Intense, and Relaxapro. The company was founded in October 1996 and is headquartered in Toronto, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

MDIN does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company